Ruedi Wealth Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-20
Closed -$298 242
2025
Q1
$298 Hold
20
﹤0.01% 318
2024
Q4
$298 Hold
20
﹤0.01% 324
2024
Q3
$383 Hold
20
﹤0.01% 326
2024
Q2
$414 Hold
20
﹤0.01% 423
2024
Q1
$376 Hold
20
﹤0.01% 251
2023
Q4
$288 Sell
20
-11
-35% -$150 ﹤0.01% 238
2023
Q3
$538 Buy
31
+20
+182% +$417 ﹤0.01% 210
2023
Q2
$229 Hold
11
﹤0.01% 216
2023
Q1
$259 Hold
11
﹤0.01% 247
2022
Q4
$307 Buy
+11
New +$281 ﹤0.01% 229

Other funds holding OGN

Ruedi Wealth Management's OGN Position: Q2 2025 in Review

Ruedi Wealth Management sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 20 shares — an estimated $298 sold.

Ruedi Wealth Management first reported a position in OGN in Q4 2022 and held it in 10 quarters. The position peaked at $538 in Q3 2023. 695 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

  • Ruedi Wealth Management reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
  • Ruedi Wealth Management sold 20 Organon & Co shares in Q2 2025, an estimated $298.
  • Ruedi Wealth Management first reported a position in Organon & Co in Q4 2022 and held it in 10 quarters.
  • Ruedi Wealth Management's Organon & Co position peaked at $538 in Q3 2023.
  • 695 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on Ruedi Wealth Management's 13F filing for Q2 2025, filed 25 Jul 2025.